Is failure to conduct reproducibility studies the latest clinical research crisis?

Pressure to publish new findings is a key reason reproducibility studies are being pushed to the wayside, researchers say.
Despite being a crucial test of a study’s quality, there are fewer incentives to reproduce research, according to findings from an international online survey.
Some 1630 biomedical researchers — covering clinical, in vivo and in vitro research — responded.
“Almost three-quarters of participants reported that they felt there was a reproducibility crisis in biomedicine,” according to the research team, which included Australia’s Monash University, Stanford University in the US and Canada’s University of Ottawa.